Clinical trials: Ciliary Motility Disorders

Primary Ciliary Dyskinesia

Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype

• Completed
• Age: 12 to 90 years
• Early Phase 1
• Results posted

The purpose of this study is to measure mucociliary clearance (MCC) in groups of subjects with the disease Primary Ciliary Dyskinesia (PCD) caused by mutations in different genes, and compare to healthy subjects.

Trial name

NCT04901715

Testing

Albuterol, Technetium99m - Sulfur Colloid (Tc99m-SC)

Where

United States

Volunteers

27 people, healthy volunteers welcome

Sponsor

University of North Carolina, Chapel Hill